Tofacitinib
NDC 27241-270, Tofacitinib, tablet, extended release, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-270
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219542
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-270-30 | 27241027030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-270-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/024bb9f2-8c26-4d9d-a33b-eb3c0a7c59edNADAC price for package 27241027030
GET /v1/drugs/nadac/27241027030
Use it
Look up 27241-270 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.